An overview of the determinants of CCR5 and CXCR4 co-receptor function

被引:111
作者
Dragic, T [1 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
关键词
D O I
10.1099/0022-1317-82-8-1807
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:1807 / 1814
页数:8
相关论文
共 109 条
  • [31] AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
    Donzella, GA
    Schols, D
    Lin, SW
    Esté, JA
    Nagashima, KA
    Maddon, PJ
    Allaway, GP
    Sakmar, TP
    Henson, G
    De Clercq, E
    Moore, JP
    [J]. NATURE MEDICINE, 1998, 4 (01) : 72 - 77
  • [32] A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
    Doranz, BJ
    GrovitFerbas, K
    Sharron, MP
    Mao, SH
    Goetz, MB
    Daar, ES
    Doms, RW
    OBrien, WA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) : 1395 - 1400
  • [33] Identification of CXCR4 domains that support coreceptor and chemokine receptor functions
    Doranz, BJ
    Orsini, MJ
    Turner, JD
    Hoffman, TL
    Berson, JF
    Hoxie, JA
    Peiper, SC
    Brass, LF
    Doms, RW
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (04) : 2752 - 2761
  • [34] Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
    Doranz, BJ
    Lu, ZH
    Rucker, J
    Zhang, TY
    Sharron, M
    Cen, YH
    Wang, ZX
    Guo, HH
    Du, JG
    Accaviti, MA
    Doms, RW
    Peiper, SC
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (09) : 6305 - 6314
  • [35] A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
    Dragic, T
    Trkola, A
    Thompson, DAD
    Cormier, EG
    Kajumo, FA
    Maxwell, E
    Lin, SW
    Ying, WW
    Smith, SO
    Sakmar, TP
    Moore, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5639 - 5644
  • [36] Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
    Dragic, T
    Trkola, A
    Lin, SW
    Nagashima, KA
    Kajumo, F
    Zhao, L
    Olson, WC
    Wu, LJ
    Mackay, CR
    Allaway, GP
    Sakmar, TP
    Moore, JP
    Maddon, PJ
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (01) : 279 - 285
  • [37] Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor
    Esté, JA
    Cabrera, C
    De Clercq, E
    Struyf, S
    Van Damme, J
    Bridger, G
    Skerlj, RT
    Abrams, MJ
    Henson, G
    Gutierrez, A
    Clotet, B
    Schols, D
    [J]. MOLECULAR PHARMACOLOGY, 1999, 55 (01) : 67 - 73
  • [38] A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry
    Farzan, M
    Vasilieva, N
    Schnitzler, CE
    Chung, S
    Robinson, J
    Gerard, NP
    Gerard, C
    Choe, H
    Sodroski, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) : 33516 - 33521
  • [39] Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
    Farzan, M
    Mirzabekov, T
    Kolchinsky, P
    Wyatt, R
    Cayabyab, M
    Gerard, NP
    Gerard, C
    Sodroski, J
    Choe, H
    [J]. CELL, 1999, 96 (05) : 667 - 676
  • [40] A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
    Farzan, M
    Choe, H
    Vaca, L
    Martin, K
    Sun, Y
    Desjardins, E
    Ruffing, N
    Wu, LJ
    Wyatt, R
    Gerard, N
    Gerard, C
    Sodroski, J
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (02) : 1160 - 1164